Outcomes among pemphigus patients who went on to receive rituximab vs. those who stayed on conventional adjuvant therapy.</p
Background: Rituximab has been reported to be effective in various small case series of patients wit...
Pemphigus is an autoimmune mucocutaneous blistering disease caused by autoantibodies against desmogl...
International audienceImportance: Rituximab and short-term corticosteroid therapy are the criterion ...
To evaluate the long-term outcomes of rituximab in the treatment of pemphigus and the influence of d...
BACKGROUND:Rituximab is a promising steroid sparing agent used in the treatment of moderate to sever...
BACKGROUND: The treatment of pemphigus is still challenging and some patients with pemphigus are unr...
Background: Pemphigus is an autoimmune disease that is challenging to treat and has few available th...
(A). Cumulative prednisone intake among patients who received prednisone plus CAT who either failed ...
Pemphigus is a rare autoimmune disease characterized by the production of pathogenic autoantibodies ...
Rituximab and intravenous immunoglobulin [IVIg] have recently emerged as effective treatments for pe...
International audiencePemphigus is a severe autoimmune blistering disease mediated by pathogenic ant...
Background: Pemphigus vulgaris patients with exclusive oral involvement (OPV) treated with conventio...
https://doi.org/10.1016/j.jaad.2019.11.023 Supplemental materials for this retrospective case series...
Background: Rituximab has been reported to be effective in various small case series of patients wit...
Pemphigus is an autoimmune mucocutaneous blistering disease caused by autoantibodies against desmogl...
International audienceImportance: Rituximab and short-term corticosteroid therapy are the criterion ...
To evaluate the long-term outcomes of rituximab in the treatment of pemphigus and the influence of d...
BACKGROUND:Rituximab is a promising steroid sparing agent used in the treatment of moderate to sever...
BACKGROUND: The treatment of pemphigus is still challenging and some patients with pemphigus are unr...
Background: Pemphigus is an autoimmune disease that is challenging to treat and has few available th...
(A). Cumulative prednisone intake among patients who received prednisone plus CAT who either failed ...
Pemphigus is a rare autoimmune disease characterized by the production of pathogenic autoantibodies ...
Rituximab and intravenous immunoglobulin [IVIg] have recently emerged as effective treatments for pe...
International audiencePemphigus is a severe autoimmune blistering disease mediated by pathogenic ant...
Background: Pemphigus vulgaris patients with exclusive oral involvement (OPV) treated with conventio...
https://doi.org/10.1016/j.jaad.2019.11.023 Supplemental materials for this retrospective case series...
Background: Rituximab has been reported to be effective in various small case series of patients wit...
Pemphigus is an autoimmune mucocutaneous blistering disease caused by autoantibodies against desmogl...
International audienceImportance: Rituximab and short-term corticosteroid therapy are the criterion ...
DOI
Add to ORKG